GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (OTCPK:HUMDF) » Definitions » Cash Flow from Others

HUMDF (Hua Medicine) Cash Flow from Others : $-14.60 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine Cash Flow from Others?

Hua Medicine's cash flow from others for the six months ended in Dec. 2024 was $-14.05 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was $-14.60 Mil.


Hua Medicine Cash Flow from Others Historical Data

The historical data trend for Hua Medicine's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hua Medicine Cash Flow from Others Chart

Hua Medicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only 3.44 1.20 -7.54 -12.68 -14.59

Hua Medicine Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.67 -2.76 -9.91 -0.54 -14.05

Hua Medicine Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-14.60 Mil.

Hua Medicine Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Hua Medicine's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Hua Medicine Business Description

Traded in Other Exchanges
Address
Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203
Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.

Hua Medicine Headlines